FDA’s Getting its Fix: The Consolidated Appropriations Act of 2026 February 6, 2026 By Sara W. Koblitz —

https://www.thefdalawblog.com/2026/02/fdas-getting-its-fix-the-consolidated-appropriations-act-of-2026/?utm_source=rss&utm_medium=rss&utm_campaign=fdas-getting-its-fix-the-consolidated-appropriations-act-of-2026 As some of you know, tucked inside the Consolidated Appropriations Act of 2026, was some legislation that FDA has been pushing for quite some time. In addition to the incredibly important renewal of the Rare Pediatric Disease Priority Review Voucher program (blog on that forthcoming), the Appropriations Act included two provisions that the Agency has been clamoring for and that directly affect drug competition.